Skip to main content

Spinal Cord Injuries

  • Chapter
Surgical Intensive Care Medicine

Abstract

Approximately, 200,000 people in the United States have spinal cord injuries (SCI), and some 10,000 new injuries occur annually. Most new victims are between 18 and 30 years old. The lifetime costs of paraplegia for such patients can exceed several million dollars in medical support and lost wages. The potential mechanisms of injury include compression, distraction, acceleration–deceleration, and shearing forces, as well as direct section from penetrating injuries.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Allen AR. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA. 1911;57:878–880.

    Article  Google Scholar 

  2. Hung TK, Albin MS, Brown TD, Bunegin L, Albin R, Jannetta PJ. Biomechanical responses to open experimental spinal cord injury. Surg Neurol. 1975;4:271–276.

    PubMed  CAS  Google Scholar 

  3. Wallace MC, Tator CH, Lewis AJ. Chronic regenerative changes in the spinal cord after cord compression injury in rats. Surg Neurol. 1987;27:209–219.

    Article  PubMed  CAS  Google Scholar 

  4. Young W. The post-injury responses in trauma and ischemia: secondary injury or protective mechanisms? Cent Nerv Syst Trauma. 1987;4:27–51.

    PubMed  CAS  Google Scholar 

  5. Young W. Secondary CNS injury. J Neurotrauma. 1988;5:219–221.

    Article  PubMed  CAS  Google Scholar 

  6. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neuorsurg. 1991;75:15–26.

    Article  CAS  Google Scholar 

  7. Tator CH. Ischemia as a secondary neuronal injury. New York: Oxford University Press; 1994.

    Google Scholar 

  8. Tator CH. Experimental and clinical studies of the pathophysio­logy and management of acute spinal cord injury. J Spinal Cord Med. 1996;19:206–214.

    PubMed  CAS  Google Scholar 

  9. Geisler F, editor. Past and current human spinal cord injury drug trials: American Association of Neurological Surgeons Publication Committee; 1995.

    Google Scholar 

  10. Geisler FH. Clinical trials of pharmacotherapy for spinal cord injury. Ann N Y Acad Sci. 1998;845:374–381.

    Article  PubMed  CAS  Google Scholar 

  11. Bracken M. Pharmacological interventions for acute spinal cord injury. Cochrane Database Syst Rev. 2000;2:CD001046.

    Google Scholar 

  12. Tator CH, Fehlings MG. Review of clinical trials of neuroprotection in acute spinal cord injury. Neurosurg Focus. 1999;6(1):e8.

    Article  PubMed  CAS  Google Scholar 

  13. Steeves JD, Lammertse D, Curt A, Fawcett JW. Experimental treatments for spinal cord injury: what you should know. International Campaign for Cures of spinal cord injury Paralysis (ICCP). Vancouver, Ca. 2007. ISBN 978-0-9782959-0-5.

    Google Scholar 

  14. Bracken MB. Methylprednisolone in the management of acute spinal cord injuries. Med J Aust. 1990;153:368.

    PubMed  CAS  Google Scholar 

  15. Steroids after spinal cord injury. Lancet 1990;336:279–280.

    Google Scholar 

  16. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405–1411.

    Article  PubMed  CAS  Google Scholar 

  17. Bracken MB. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. J Neurotrauma. 1991;8(Suppl 1):S47–S50. discussion S51–S52.

    PubMed  Google Scholar 

  18. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992;76:23–31.

    Article  PubMed  CAS  Google Scholar 

  19. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg. 1993;79:500–507.

    Article  PubMed  CAS  Google Scholar 

  20. Otani K, Kadoya S, et al. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury. Sekitsui Sekizui J. 1994;7:633–647.

    Google Scholar 

  21. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277:1597–1604.

    Article  PubMed  CAS  Google Scholar 

  22. Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg. 1998;89:699–706.

    Article  PubMed  CAS  Google Scholar 

  23. Geisler FH, Dorsey FC, Coleman WP. Correction: recovery of motor function after spinal-cord injury – a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991;325:1659–1660.

    PubMed  CAS  Google Scholar 

  24. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury – a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991;324:1829–1838.

    Article  PubMed  CAS  Google Scholar 

  25. Geisler FH, Dorsey FC, Coleman WP. GM-1 ganglioside in human spinal cord injury. J Neurotrauma. 1992;9(suppl 1):S407–S416.

    PubMed  Google Scholar 

  26. Geisler FH. GM-1 ganglioside and motor recovery following human spinal cord injury. J Emerg Med. 1993;11(Suppl 1):49–55.

    PubMed  Google Scholar 

  27. Geisler FH, Dorsey FC, Coleman WP. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann Emerg Med. 1993;22:1041–1047.

    Article  PubMed  CAS  Google Scholar 

  28. Geisler FH, Dorsey FC, Patarnello F, Grieco G, Poonian D, Fiorentini R. SYGEN acute spinal cord injury study (abstract). J Neurotrauma. 1998;15:868.

    Google Scholar 

  29. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251:45–52.

    Article  PubMed  CAS  Google Scholar 

  30. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg. 1985;63:704–713.

    Article  PubMed  CAS  Google Scholar 

  31. Bracken MB. Pharmacological treatment of acute spinal cord injury: current status and future projects. J Emerg Med. 1993;11(Suppl 1):43–48.

    PubMed  Google Scholar 

  32. Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine. 2006;31:E250–E253.

    Article  PubMed  Google Scholar 

  33. Taylor TK, Ryan MD. Methylprednisolone in the management of acute spinal cord injuries. Med J Aust. 1990;153:307–308.

    PubMed  CAS  Google Scholar 

  34. Rosner MJ. National acute spinal cord injury study of methylprednisolone or naloxone. Neurosurgery. 1991;28:628–629.

    Article  PubMed  CAS  Google Scholar 

  35. Rosner MJ. Methylprednisolone for spinal cord injury. J Neurosurg. 1992;77:324–325. discussion 325–327.

    PubMed  CAS  Google Scholar 

  36. Shapiro SA. Methylprednisolone for spinal cord injury. J Neurosurg. 1992;77:324. discussion 325–327.

    PubMed  CAS  Google Scholar 

  37. Rosner MJ. Treatment of spinal cord injury. J Neurosurg. 1994;80:954–955.

    PubMed  CAS  Google Scholar 

  38. Ducker TB. Medical treatment in spinal cord injuries. J Spinal Disord. 1996;9:381.

    Article  PubMed  CAS  Google Scholar 

  39. Hardy R. Commentary on spinal cord injury: role of steroid therapy. Neurosurg Quart. 1996;6:71–72.

    Article  Google Scholar 

  40. Hanigan WC, Anderson RJ. Commentary on NASCIS-2. J Spinal Disord. 1992;5:125–131. discussion 132–133.

    Article  PubMed  CAS  Google Scholar 

  41. Ducker TB, Zeidman SM. Spinal cord injury. Role of steroid therapy. Spine. 1994;19:2281–2287.

    Article  PubMed  CAS  Google Scholar 

  42. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma. 1998;45:1088–1093.

    Article  PubMed  CAS  Google Scholar 

  43. Coleman WP, Benzel E, Cahill DW, et al. A critical appraisal of the reporting of the NASCIS II and III studies of MPSS in acute spinal cord injury. J Spinal Disord. 2000;13(3):185–199.

    Article  PubMed  CAS  Google Scholar 

  44. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg. 2000;93:1–7.

    Article  PubMed  CAS  Google Scholar 

  45. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma. 1998;45:1088–1093.

    Article  PubMed  CAS  Google Scholar 

  46. Short DJ, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: a systematic review from a clinical perspective. Spinal Cord. 2000;38:273–286.

    Article  PubMed  CAS  Google Scholar 

  47. Hurlbert RJ. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine. 2001;26(24S):S39–S46.

    Article  PubMed  CAS  Google Scholar 

  48. Hadley MN, Walters BC. “Pharmacological therapy after acute cervical spinal cord injury” in Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2002;50:S63–S72.

    Article  Google Scholar 

  49. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ. 2003;168:1145–1146.

    PubMed  Google Scholar 

  50. Hurlbert RJ. Strategies of medical intervention in the management of acute spinal cord injury. Spine. 2006;31:S16–S21.

    Article  PubMed  Google Scholar 

  51. Sayer FT, Kronvall E, Nilsson OG. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J. 2006;6:335–343.

    Article  PubMed  Google Scholar 

  52. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365:1957–1959.

    Article  PubMed  Google Scholar 

  53. Geisler FH, Dorsey FC, Coleman WP. GM-1 ganglioside in human spinal cord injury. J Neurotrauma. 1992;9(suppl 2):S517–S530.

    PubMed  Google Scholar 

  54. Geisler FH, Coleman WP, Dorsey FC, Grieco G, Poonian D. Recruitment and early care after acute spinal cord injury. Spine. 2001;26(24S):58–67.

    Article  Google Scholar 

  55. Geisler FH, Coleman WP, Dorsey FC, Grieco G, Poonian D. Measurement and recovery after acute spinal cord injury. Spine. 2001;26(24S):68–86.

    Article  Google Scholar 

  56. Geisler FH, Coleman WP, Dorsey FC, Grieco G, Poonian D. A multi-center trial of GM-1 ganglioside in acute spinal cord injury. Spine. 2001;26(24S):87–98.

    Article  Google Scholar 

  57. Oleson CV, Burns AS, Ditunno JF, Geisler FH, Coleman WP. Prognostic value of pinprick preservation in motor complete, sensory incomplete spinal cord injury. Arch Phys Med Rehabil. 2005;86:988–992.

    Article  PubMed  Google Scholar 

  58. Fawcett JW, Curt A, Steeves JD, Coleman WP. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 2007;45:190–205.

    Article  PubMed  CAS  Google Scholar 

  59. Steeves JD, Lammertse D, Curt A, Fawcett JW. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord. 2007;45:206–221.

    Article  PubMed  CAS  Google Scholar 

  60. Tadie M, et al. Early care and treatment with a neuroprotective drug, gacyclidine, in patients with acute spinal cord injury. Rachis. 2003;15:363–376.

    Google Scholar 

  61. Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma. 1995;12:235–243.

    Article  PubMed  CAS  Google Scholar 

  62. Petitjean ME, Pointillart V, Dixmerias F, et al. Medical treatment of spinal cord injury in the acute stage. Ann Fr Anesth Reanim. 1998;17:114–122.

    Article  PubMed  CAS  Google Scholar 

  63. Knoller N, Auerbach G, Fulga V, Zelig G. Clinical experience using incubated macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine. 2005;3:173–181.

    Article  PubMed  Google Scholar 

  64. Segal JL, Hayes KC, Brunnemann SR, et al. Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injury. J Clin Pharmacol. 2000;40:402–409.

    Article  PubMed  CAS  Google Scholar 

  65. Potter PJ, Hayes KC, Segal JL, et al. Randomized double-blind crossover trial of fampridine-SR (sustained release 4 aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma. 1998;10:837–849.

    Article  Google Scholar 

  66. Cardenas DD, Ditunno J, Graziani V, et al. Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord. 2007;45(2):158–168.

    Article  PubMed  CAS  Google Scholar 

  67. Borgens RB, Blight AR, McGinnis ME. Functional recovery after spinal cord hemisection in Guinea pigs: the effects of applied electric fields. J Comp Neurol. 1990;296:634–653.

    Article  PubMed  CAS  Google Scholar 

  68. Borgens RB, Toombs JP, Blight AR, et al. Effects of applied electric fields on clinical cases of complete paraplegia in dogs. Restor Neurol Neurosci. 1993;5:305–322.

    PubMed  CAS  Google Scholar 

  69. Borgens RB, Toombs JP, Breur G, et al. An imposed oscillating electrical field improves the recovery of function in neurologically complete paraplegic dogs. J Neurotrauma. 1999;16(7):639–657.

    Article  PubMed  CAS  Google Scholar 

  70. Shapiro S, Borgens R, Pascuzzi R, et al. Oscillating field stimulation for complete spinal cord injury in humans: a phase I trial. J Neurosurg Spine. 2005;2:3–10.

    Article  PubMed  Google Scholar 

  71. Walters BC, Coleman WP, Shapiro SA, Borgens RB, Geisler FH. Comparison of outcomes of oscillating field stimulation in AIS a patients to spontaneous recovery alone. Presented at the 24th Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves, Orlando, Florida, March 1, 2008.

    Google Scholar 

  72. Fehlings MG, Tator CH. An evidence-based review of decompressive surgery in acute spinal cord injury: rationale, indications, and timing based on experimental and clinical studies. J Neurosurg. 1999;91(1 suppl):1–11.

    PubMed  CAS  Google Scholar 

  73. Kirshblum S. New rehabilitation interventions in spinal cord injury. J Spinal Cord Med. 2004;27:342–350.

    PubMed  Google Scholar 

  74. Gaunt RA, Prochazka A. Control of urinary bladder function with devices: successes and failures. Prog Brain Res. 2006;152:163–194.

    Article  PubMed  Google Scholar 

  75. http://www.icord.org/scire/home.php.

  76. Dunham CM, Cowley RA. Shock trauma/critical care handbook. Rockville, MD: Aspen Publishers; 1986.

    Google Scholar 

  77. Levine AM, editor. Acute spinal injury. Orthop Clin North Am. 1986;17:1–203.

    Google Scholar 

  78. Benzel EC, Tator CH, editors. Contemporary management of spinal cord injury. Park Ridge, IL: American Association of Neurological Surgeons; 1995.

    Google Scholar 

  79. Capen DA, Haye W. Comprehensive management of spine trauma. St. Louis: Mosby; 1998.

    Google Scholar 

  80. Levine AM, Eismont FJ, Garfin SR. Spine trauma. Philadelphia: Saunders; 1998.

    Google Scholar 

  81. International Standards for Neurological Classification of Spinal Cord Injury. Chicago: American Spinal Injury Association; 2000, reprinted 2002.

    Google Scholar 

  82. Reference Manual for the International Standards for Neurological Classification of Spinal Cord Injury. Chicago: American Spinal Injury Association; 2003.

    Google Scholar 

  83. Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma. 2004;21(10):1371–1383.

    Article  PubMed  Google Scholar 

  84. Hamilton BB, Fuhrer MJ. Rehabilitation outcomes: analysis and measurement. Baltimore: Brooks; 1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Geisler, F.H., Coleman, W.P. (2010). Spinal Cord Injuries. In: O’Donnell, J.M., Nácul, F.E. (eds) Surgical Intensive Care Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77893-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-77893-8_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-77892-1

  • Online ISBN: 978-0-387-77893-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics